Published in Proc Natl Acad Sci U S A on December 22, 2014
Novel endogenous angiogenesis inhibitors and their therapeutic potential. Acta Pharmacol Sin (2015) 0.87
Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol (2015) 0.83
Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome. Nat Cell Biol (2015) 0.83
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development. Cell Death Dis (2016) 0.82
p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability. Oncotarget (2016) 0.82
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget (2016) 0.81
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis. Cell Death Dis (2015) 0.79
Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients. Aging (Albany NY) (2015) 0.78
TAp73 transcriptionally represses BNIP3 expression. Cell Cycle (2015) 0.77
Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse model. Cancer Gene Ther (2015) 0.77
DUBs, New Members in the Hypoxia Signaling clUb. Front Oncol (2016) 0.77
The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget (2015) 0.77
Ultraconserved long non-coding RNA uc.63 in breast cancer. Oncotarget (2016) 0.76
Metabolic pathways regulated by TAp73 in response to oxidative stress. Oncotarget (2016) 0.76
Novel role of p73 as a regulator of developmental angiogenesis: Implication for cancer therapy. Mol Cell Oncol (2015) 0.75
Inhibition of cancer antioxidant defense by natural compounds. Oncotarget (2016) 0.75
p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression. Oncotarget (2016) 0.75
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis. J Vis Exp (2016) 0.75
p73: a Positive or Negative Regulator of Angiogenesis, or Both? Mol Cell Biol (2015) 0.75
Antidepressants synergize with chemotherapy against cancer stem cells. Aging (Albany NY) (2015) 0.75
TAp73 upregulates IL-1β in cancer cells: Potential biomarker in lung and breast cancer? Biochem Biophys Res Commun (2017) 0.75
A compendium of proteins that interact with HIF-1α. Exp Cell Res (2017) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51
Signaling to p53: breaking the MDM2-p53 circuit. Cell (1998) 8.63
Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer (2011) 6.32
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (2000) 5.83
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev (2000) 5.16
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci (2012) 4.96
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev (2008) 4.85
HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell (2001) 4.75
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell (2005) 4.14
Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol (1994) 3.05
Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res (2011) 2.81
Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem (2002) 2.15
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell (2014) 2.12
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev (2010) 2.06
MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol (1999) 2.00
Mdm2 binds p73 alpha without targeting degradation. Oncogene (1999) 1.62
The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer (2013) 1.36
Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A (2002) 1.18
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene (2001) 1.02
Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene (2000) 0.97
MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem (2014) 0.92
Cutaneous two-stage chemical carcinogenesis. CSH Protoc (2007) 0.86